Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sepideh F Varon

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of Managed Care Pharmacy : JMCP|December 31, 2013
Systematic review of migraine prophylaxis adherence and persistenceZsolt Hepp, Lisa M Bloudek, Sepideh F Varon
Pain Practice : the Official Journal of World Institute of Pain|February 4, 2012
Adherence with migraine prophylaxis in clinical practiceAriel Berger, Lisa M Bloudek, Sepideh F Varon, et al.
Cephalalgia : an International Journal of Headache|September 8, 2010
Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraineMin Yang, Regina Rendas-Baum, Sepideh F Varon, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 17, 2012
The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patientsRegina Rendas-Baum, Lisa M Bloudek, Gregory A Maglinte, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|May 8, 2013
Adherence associated with oral medications in the treatment of spasticityRachel Halpern, Patrick Gillard, Glenn D Graham, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Mapping from disease-specific measures to health-state utility values in individuals with migrainePatrick J Gillard, Beth Devine, Sepideh F Varon, et al.
Headache|October 10, 2014
Real-world economic impact of onabotulinumtoxinA in patients with chronic migraineJohn F Rothrock, Lisa M Bloudek, Timothy T Houle, et al.
Cephalalgia : an International Journal of Headache|August 29, 2014
Adherence to oral migraine-preventive medications among patients with chronic migraineZsolt Hepp, David W Dodick, Sepideh F Varon, et al.
Cephalalgia : an International Journal of Headache|December 23, 2015
Comparative effectiveness of onabotulinumtoxinA versus oral migraine prophylactic medications on headache-related resource utilization in the management of chronic migraine: Retrospective analysis of a US-based insurance claims databaseZsolt Hepp, Noah L Rosen, Patrick G Gillard, et al.
Journal of Occupational and Environmental Medicine|September 14, 2011
A case study for calculating employer costs for lost productive time in episodic migraine and chronic migraine: results of the American Migraine Prevalence and Prevention StudyWalter F Stewart, Christa Bruce, Aubrey Manack, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Managed Care Pharmacy : JMCP|December 31, 2013
Systematic review of migraine prophylaxis adherence and persistenceZsolt Hepp, Lisa M Bloudek, Sepideh F Varon
Pain Practice : the Official Journal of World Institute of Pain|February 4, 2012
Adherence with migraine prophylaxis in clinical practiceAriel Berger, Lisa M Bloudek, Sepideh F Varon, et al.
Cephalalgia : an International Journal of Headache|September 8, 2010
Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraineMin Yang, Regina Rendas-Baum, Sepideh F Varon, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 17, 2012
The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patientsRegina Rendas-Baum, Lisa M Bloudek, Gregory A Maglinte, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|May 8, 2013
Adherence associated with oral medications in the treatment of spasticityRachel Halpern, Patrick Gillard, Glenn D Graham, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 16, 2012
Mapping from disease-specific measures to health-state utility values in individuals with migrainePatrick J Gillard, Beth Devine, Sepideh F Varon, et al.
Headache|October 10, 2014
Real-world economic impact of onabotulinumtoxinA in patients with chronic migraineJohn F Rothrock, Lisa M Bloudek, Timothy T Houle, et al.
Cephalalgia : an International Journal of Headache|August 29, 2014
Adherence to oral migraine-preventive medications among patients with chronic migraineZsolt Hepp, David W Dodick, Sepideh F Varon, et al.
Cephalalgia : an International Journal of Headache|December 23, 2015
Comparative effectiveness of onabotulinumtoxinA versus oral migraine prophylactic medications on headache-related resource utilization in the management of chronic migraine: Retrospective analysis of a US-based insurance claims databaseZsolt Hepp, Noah L Rosen, Patrick G Gillard, et al.
Journal of Occupational and Environmental Medicine|September 14, 2011
A case study for calculating employer costs for lost productive time in episodic migraine and chronic migraine: results of the American Migraine Prevalence and Prevention StudyWalter F Stewart, Christa Bruce, Aubrey Manack, et al.
Pageof 3